Sadık Muallaoğlu

Liv Hospital Ankara

Medical Oncology

Hospital

Please Select Hospital!

Choose Department

All Branches

Before Noon

Afternoon

You must select a hospital to make an appointment.

You can call our Call Center at 444 4 548 for available appointment slots and information.

Make an Appointment

Areas of Interests

Breast Cancer
Lung cancer
Colon cancer
Gastric cancer
Pancreatic Cancer
Prostate cancer
Bladder Cancer
Ovarian, Endometrium, Cervix Cancers
Testicular Lymphomas and Other Cancers

h-index

Education:

Ministry of Health Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Medical Oncology, 2003-2007
Dicle University, Internal Medicine, 1988-1992
Faculty of Medicine Çukurova University, 1980-1986

Experience:

İskenderun Gelişim Hospital, Medical Oncology, 2016-2023
Başkent University, Medical Oncology, 2011-2015
Ankara Bayındır Hospital, Medical Oncology, 2009-2011
Mersin State Hospital, Medical Oncology Specialist, 2007- 2009
Adana State Hospital, Internal Medicine Specialist, 1997- 2003

A-Articles published in internationally refereed journals:

1-Onal C, Kose F, Ozyigit G, Aksoy S, Oymak E, Muallaoglu S, Guler OC, Tilki B, Hurmuz P, Akyol F. Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment. Prostate. 2021 Jun;81(9):543-552. doi: 10.1002/pros.24132. Epub 2021 Apr 27. PMID: 33905131

2- Koçer M, Muallaoglu S, Cetin B, Coskun Hs, Karahan N, Gurdal O. Second Primary Tumors in Patients with Gastrointestinal Stromal Tumors: A Single-Center Experience. Medicina (Kaunas). 2021 May 13;57(5):494. doi: 10.3390/medicina57050494. PMID: 34068309

3- Yildirim BA, Onal C, Kose F, Oymak E, Sedef AM, Besen AA, Aksoy S, Guler OC, Sumbul AT, Muallaoglu S, Mertsoylu H, Ozyigit G. Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Strahlenther Oncol. 2019 Oct;195(10):872-881. doi: 10.1007/s00066-019-01429-6. Epub 2019 Jan 30. PMID: 30701292

4- Onal C, Sedef AM, Kose F, Oymak E, Guler OC, Sumbul AT, Aksoy S, Akkus Yildirim B, Besen AA, Muallaoglu S, Mertsoylu H, Ozyigit G. The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Future Oncol. 2019 May;15(13):1469-1479. doi: 10.2217/fon-2018-0635. Epub 2019 Apr 12. PMID: 30977383

5- Mertsoylu H, Köse F, Sümbül AT, Sedef AM, Doğan Ö, Besen AA, Parlak C, Findikcioglu A, Muallaoglu S, Sezer A, Sakalli H, Ozyilkani O. Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experience. Med Sci Monit. 2015 Mar 3;21:661-6. doi: 10.12659/MSM.892730. PMID: 25731741

6- Sedef AM, Köse F, Doğan Ö, Ergun T, Sezer A, Mertsoylu H, Muallaoglu S, Besen A, Ozyilkani O. Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases. Mol Clin Oncol. 2015 Mar;3(2):400-402. doi: 10.3892/mco.2014.456. Epub 2014 Nov 13. PMID: 25798275

7-Sedef AM, Köse F, Sümbül AT, Doğan Ö, Beşen AA, Tatlı AM, Mertsoylu H, Sezer A, Muallaoğlu S, Özyılkan Ö, Abalı H. Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit? MedOncol. 2015 Feb;32(2):476. doi: 10.1007/s12032-014-0476-8. Epub 2015 Jan 9. PMID: 25572818

8-Sezer A, Sümbül AT, Abali H, Mertsoylu H, Muallaoğlu S, Köse F, Ozyilkan O. Gemcitabine + platinum combination chemotherapy in patients with metastatic cancer who suffer from severe and irreversible hepatic impairment: a single center experience. Hepatogastroenterology. 2014 Oct;61(135):1895-900. PMID: 25713885

9- Sümbül AT, Sezer A, Abalı H, Köse F, Gültepe I, Mertsoylu H, Muallaoğlu S, Özyılkan Ö. Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel. Int Urol Nephrol. 2014 Aug;46(8):1531-5. doi: 10.1007/s11255-014-0664-7. Epub 2014 Feb 13. PMID: 24526335

10- Muallaoglu S, Disel U, Tekin A, Mertsoylu H, Abali H, Ozyilkan O. Prolonged use of bevacizumab may cause extensive coronary artery thrombosis. J BUON. 2014 Apr-Jun;19(2):578-9. PMID: 24965427

11-Muallaoglu S, Karadeniz C, Mertsoylu H, Ayberk Besen A, Sezer A, Murat Sedef A, Kose F, Ozyilkan O. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer. J BUON. 2014 Apr-Jun;19(2):453-8. PMID: 24965406

12- Mertsoylu H, Muallaoglu S, Besen AA, Erdogdu S, Sezer A, Sedef AM, Kose F, Arican A, Ozyilkan O. Primary extranodal non-Hodgkin's lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey. Asian Pac J Cancer Prev. 2014;15(17):7207-11. doi: 10.7314/apjcp.2014.15.17.7207. PMID: 25227815

13- Sezer A, Sumbul AT, Abali G, Sumbul Z, Muallaoglu S, Abali H. Can low molecular weight heparins circumvent the problem of coumadine and chemotherapy interaction in cancer patients with prosthetic heart valves? Asian Pac J Cancer Prev. 2014;15(4):1889-90. doi:10.7314/apjcp.2014.15.4.1889. PMID: 24641426

14- Muallaoglu S, Besen AA, Ata A, Mertsoylu H, Arican A, Kayaselcuk F, Ozyilkan O. Lack of prognostic significance of C-erbB-2 expression in low- and high-grade astrocytomas. Asian Pac J Cancer Prev. 2014;15(3):1333-7. doi: 10.7314/apjcp.2014.15.3.1333. PMID: 24606461

15- Muallaoglu S, Ustun I, Kaya Y, Leblebici I. Lung tuberculosis causing false positivity on positron emission tomography. J BUON. 2013 Jul-Sep;18(3):800. PMID: 24065504

16- Muallaoglu S, Karagun O, Mertsoylu H, Besen AA, Sezer A, Ozyilkan O. Attributes of cancer patients admitted to the emergency department in one year. WJEM 5 Issue2 Page 85-90 DOI 10.5847/wjem.j.issn.1920-8642.2014.02.001

17-Abali H, Sezer A, Oğuzkurt L, Gürel K, Özkan U, Beşen AA, Sümbül AT, Köse F, Dışel U, Muallaoğlu S, Özyılkan Ö. Which patients with advanced cancer and biliary obstruction benefit from biliary stenting most? An analysis of prognostic factors. Support Care Cancer. 2013 Apr;21(4):1131-5. doi: 10.1007/s00520-012-1636-z. Epub 2012 Nov 8. PMID: 23132146

18-Muallaoglu S, Disel U, Mertsoylu H, Besen A, Karadeniz C, Taner Sumbul A, Abali H, Ozyilkan O. Acute infusion reactions to chemotherapeutic drugs: a single institute experience. J BUON. 2013 Jan-Mar;18(1):261-7. PMID: 23613414

19-Dişel U, Beşen A, Karadeniz C, Mertsoylu H, Sezer A, Köse F, TanerSümbül A, Gürkut O, Muallaoğlu S, Abali H, Ozyilkan O. Prevalence of thyroid dysfunction in untreated cancer patients: a cross-sectional study. MedOncol. 2012 Dec;29(5):3608-13. doi: 10.1007/s12032-012-0254-4. Epub 2012 May 22. PMID: 22729367

20- Muallaoğlu S, Koçer M, Güler N. Acute transient encephalopathy after weekly paclitaxel infusion. MedOncol. 2012 Jun;29(2):1297-9. doi: 10.1007/s12032-011-9956-2. Epub 2011 May 27. PMID: 21618057

21- Muallaoglu S, Ozdemir E, Kutluay L. Intracystic papillary carcinoma of the breast in a male patient: a case report. Case Rep Med. 2012;2012:378157. doi: 10.1155/2012/378157. Epub 2012 Oct 30. PMID: 23251172

22- Alkis N, Durnali AG, Arslan UY, Kocer M, Onder FO, Tokluoglu S, Celenkoglu G, Muallaoglu S, Utkan G, Ulas A, Altundag K. Optimal timing of adjuvant treatment in patients with early breast cancer. MedOncol. 2011 Dec;28(4):1255-9. doi: 10.1007/s12032-010-9566-4. Epub 2010 May 15. PMID: 20473647

23- Alkis N, Muallaoğlu S, Koçer M, Arslan üY, Durnalı AG, Tokluoğlu S, Çelenkoğlu G, Paksoy F, Coskun U. Primary adult soft tissue sarcomas: analysis of 294 patients. MedOncol. 2011 Mar;28(1):391-6. doi: 10.1007/s12032-010-9450-2. Epub 2010 Feb 24. PMID: 20180160

24- Utkan G, Tek I, Kocer M, Muallaoglu S, Durnal AG, Arslan UY, Celenkoglu G, Tokluoglu S, Alkis N. Blood viscosity in patients with diffuse large B cell non-Hodgkin's lymphoma. Exp Oncol. 2006 Dec;28(4):326-7.

B- Presentations presented in international scientific meetings and published in proceedings:

1-Utkan G, Alpay A, Muallaoglu S, Tokluoglu S, Durnali AG, Arslan UY, Kocer M ,Celenkoglu G, Akbulut H, Alkis N (2006). Hepatitis B and C seroprevalance in cancer patients: A case control study. 31st ESMO Congress. (Abstract Presentation/Poster)(Publication No:5590164)

2-Alkis N,Utkan G,Durnali AG, Arslan ,Arslan UY,Celenkoglu G, Tokluoglu S, Kocer M, Muallaoglu S(2006). Epidemologic properties of patients who had admitted to Ankara Oncology Hospital department of Medical Oncology.. 31st ESMO Congress. (Abstract Presentation/Poster)(Publication No:5588504)

3-Arslan UY,Utkan G,Kocer M, Muallaoglu S, Tokluoglu S, celenkoglu G, Durnali AG, Ozturk M, Ibrahim T, Alkis N (2006). A hundred and fiftyteen Non-Hodgkin lymphoma’s patients characteristics.. 31st ESMO Congress (Abstract Presentation/Poster)(Publication No:5590339)

4-Muallaoglu S, Utkan G, Kocer M, Celenkoglu G, Tokluoglu S, Durnali AG, Arslan UY,Tek I,Ozturk M, Alkis N Dermatofibrosarcoma protuberans our experience in 10 patients.. 31st ESMO Congress. (Abstract Presentation/Poster)(Publication No:5590133)

5- Utkan G,Tek I,Kocer M,Tokluoğlu S,Muallaoğlu S,Arslan UY,Celenkoğlu G, Durnalı AG, Alkıs N (2006). Is serum viscosity a new prognostic factor in Non-Hodgkin’s lyphoma patients?. 31st ESMO Congress (Abstract Presentation/Poster)(Publication No:5590384)

6- Durnalı AG, Alkıs N,Utkan G, Celenkoglu G,Arslan UY, Muallaoglu S,Kocer M,Tokluoglu S (2006). What is the optimal starting time of adjuvant treatment in breast cancer patients?. 31st ESMO Congress (Abstract Presentation/Poster) (Publication No: 5590272)

7- Muallaoğlu S, Utkan G, Kocer M, Durnalı AG, Arslan UY, Celenkoğlu G, Tokluoğlu S, Ozturk M, Alkış N (2006). The characteristics of malignant fibrous histiocytoma in 33 cases.. 31st ESMO Congress. (Abstract Presentation/Poster) (Publication No: 5588509)

8- Arslan UY, Utkan G, durnalı AG, Celenkoğlu G, Kocer M, Tokluoglu S, Muallaoglu S, Ozturk M Alkıs N. (2006). Outcome of the sixteen thymoma and thymic carcinoma patients..31st ESMO Congress (Abstract Presentation/Poster)(Publication No:5590204)

9-Tokluoğlu S, Muallaoğlu S, Kocer M, Celenkoglu G, arslan UY, Durnalı AG,Ozturk M, Tek I, Alkıs N , Utkan G, (2006). Multiple primary tumors in 45 cases. 31st ESMO Congress. (Abstract Presentation/Poster)(Publication No:5588542)

C- Articles published in national refereed journals

1- Arguder E, Hızer SB, Aydın D, Davla I, Muallaoglu S, Koksal A, Akhan O. Rapidly developing malignant pleural fluid in a patient with renal cell carcinoma. İzmir Chest Hospital Journal 2012, 16(2):137-141.

2- Muallaoglu S, Kocer M. Evaluation of clinical features of patients diagnosed with breast cancer during hemodialysis treatment. Süleyman Demirel University Medical Faculty Journal, 2011:18(4):123-125.

3-Celenkoglu G, Utkan G, Irkkan C, Benzer E, Arslan UY, Tokluoglu S, Muallaoglu S, Kocer M, Alkıs N. Pancreatic non-Hodgkin lymphoma case. National Hematology Oncology Journal 2007 Issue 2 volume 17, pages 108-111.

4- Kocer M, Utkan G, Ardıç F, Tokluoglu S, Muallaoglu S, Durnalı AG, Arslan UY, Celenkoglu G, Alkıs N. Multiple Primary Malignancies in a patient: Astrocytoma, Malign Mesenchymal Tumor and Pancreatic Tumor. National Hematology Oncology Journal 2007 Issue 4 volume 17, pages 236-240.

5- Utkan G, Azap A, Muallaoglu S, Tokluoglu S, Durnali AG, Arslan UY, Kocer M, Celenkoglu G, Akbulut H, Alkis N. Prevalence of Hepatitis B and C in patients with cancer: Case Control Study. National Journal of Hematology Oncology 2006 issue 3 volume 16, pages 103-107.

6- Muallaoglu S, Utkan G, Durnali AG, Arslan UY, Kocer M, Tokluoglu S, Celenkoglu G, Alkis N, Ozturk M. A case of lung epidermoid carcinoma with bilateral adrenal metastases presenting with Addisonian Crisis. Acta Oncologica Turcica 2005,38; 1, 34-37.

7- Canoruc F, Muallaoglu S, Yenicene N, Degertekin H, Goral V, Canoruc N. Frequency of anti-HCV in volunteer blood donors. T Klin Gastroenterohepatology, 1993,4: 130-132.

D. Papers presented at national scientific meetings and published in proceedings books:

1- Ülkü Yalçıntaş Arslan, Saadet Tokluoğlu, Ayşe Durnalı, Gökhan Çelenkoğlu, Murat Koçer, Sadık Muallaoğlu, Güngör Utkan, Necati Alkış. Single-center 265 breast cancer experience. 2nd Medical Oncology Congress. March 26-30, 2008 Antalya.

2- Ülkü Yalçıntaş Arslan, Güngör Utkan, Ayşe Durnalı, Saadet Tokluoğlu, Gökhan Çelenkoğlu, Murat Koçer, Sadık Muallaoğlu, Necati Alkış. Male breast cancer: Single-center experience. 2nd Medical Oncology Congress. March 26-30, 2008 Antalya.

3- Ülkü Yalçıntaş Arslan, Gökhan Çelenkoğlu, Emine Benzer, Sadık Muallaoğlu, Murat Koçer, Saadet Tokluoğlu, Güngör Utkan, Necati Alkış. Multicentric Castleman disease Case report. XVII. National cancer congress. April 19-23, 2007 Antalya

4- Saadet Tokluoğlu, Murat Koçer, Sadık Muallaoğlu, Gökhan Çelenkoğlu, Ülkü Yalçıntaş Arslan, Güngör Utkan, Necati Alkış. Demographic characteristics of 100 thyroid cancer patients admitted to Ankara Oncology Hospital. XVII. National cancer congress. April 19-23, 2007 Antalya

5- Necati Alkış, Gökhan Çelenkoğlu, Ülkü Yalçıntaş Arslan, Güngör Utkan, Saadet Tokluoğlu, Sadık Muallaoğlu, Murat Koçer. Cultural levels and perspectives of Ankara Oncology Hospital Patients. XVII. National Cancer Congress. April 19-23, 2007 Antalya

6- Sadık Muallaoğlu, Murat Koçer, Saadet Tokluoğlu, Ülkü Yalçıntaş Arslan, Gökhan Çelenkoğlu, Güngör Utkan, Necati Alkış. Regional distribution of soft tissue sarcoma patients admitted to Ankara Oncology Hospital. XVII. National Cancer Congress. April 19-23, 2007 Antalya

7- Murat Koçer, Sadık Muallaoğlu, Saadet Tokluoğlu, Ülkü Yalçıntaş Arslan, Gökhan Çelenkoğlu, Güngör Utkan, Necati Alkış. Characteristics of female lung cancer cases treated in Ankara Oncology Hospital in 2006. XVII. National Cancer Congress. April 19-23, 2007 Antalya.

8- Murat Koçer, Sadık Muallaoğlu, Saadet Tokluoğlu, Ülkü Yalçıntaş Arslan, Gökhan Çelenkoğlu, Güngör Utkan, Gülay Bilir Dilek, Necati Alkış. Small cell lung carcinoma presenting with pancreatic metastasis and obstructive jaundice. XVII. National cancer congress. April 19-23, 2007 Antalya

9- Murat Koçer, Sadık Muallaoğlu, Saadet Tokluoğlu, Ülkü Yalçıntaş Arslan, Gökhan Çelenkoğlu, Ayşe Gök Durnalı, Güngör Utkan, Işın Pak, Necati Alkış. A case of non-small cell lung cancer presenting with gastrointestinal system metastasis. XVII. National Cancer Congress. April 19-23, 2007 Antalya

10- Gökhan Çelenkoğlu, Özlem Altay Akman, Ülkü Yalçıntaş Arslan, Saadet Tokluoğlu, Sadık Muallaoğlu, Murat Koçer, Güngör Utkan, Necati Alkış. Esophageal cancer bullous pemphigoid case. XVII. National Cancer Congress. April 19-23, 2007 Antalya

11- Gökhan Çelenkoğlu, Hüseyin Üstün, Ülkü Yalçıntaş Arslan, Murat Koçer, Sadık Muallaoğlu, Saadet Tokluoğlu, Güngör Utkan, Necati Alkış. Adult pancreoblastoma case. XVII. National Cancer Congress. April 19-23, 2007 Antalya

12- Necati Alkış, Ayşe Gök, Ülkü Yalçıntaş Arslan, Gökhan Çelenkoğlu, Saadet Tokluoğlu, Murat Koçer, Sadık Muallaoğlu. Ankara Oncology Hospital Medical Oncology Department, cancer patient distribution in 1999 and 2000. XVI. National cancer congress. April 20-24, 2005, Antalya.

13- Sadık Muallaoğlu, Necati Alkış, Murat Koçer, Saadet Tokluoğlu, Ayşe Gök, Ülkü Yalçıntaş Arslan, Gökhan Çelenkoğlu, Işın Pak. Primary gastric plasmacytoma, XVI. National cancer congress. April 20-24, 2005, Antalya

E. In terms of Congress Activities:

1- Moderatorship of the Treatment Session in Rare Tumors of Breast Cancers in the Turkish Medical Oncology Congress. 05/19/2022 Antalya.

2- Turkish Medical Oncology Congress Gynecological Cancers with Cases Session Speaker. 03/23/2018 Antalya.

3- Palliative care for cancer patients: are we on the right direction? Speaker, UICC 23rd Melbourne , Australia December 3-6 , 2014.

4- Hematology Specialist Association Education Meetings. 1-2 June BAKU Supportive Treatments in Cancer Presentation.

• Turkish Medical Oncology Association
• Oncology and Immunotherapy Association
• Turkish Internal Medicine Specialist Association
• ESMO
• ASCO